浏览全部资源
扫码关注微信
系统免疫炎症指数与2型糖尿病下肢血管病变的相关性研究
Correlation between systemic immune-inflammation index and lower extremity vascular disease in patients with type 2 diabetes mellitus
- 陆军军医大学学报 2024年46卷第18期 页码：2138-2144
- 作者机构：
400042 重庆，陆军特色医学中心高血压内分泌科，全军高血压代谢病中心，重庆市高血压研究所
- 作者简介：
[闫振成, E-mail: zhenchengyan2024@tmmu.edu.cnYAN Zhencheng, E-mail: zhenchengyan2024@tmmu.edu.cn
- 基金信息：国家自然科学基金面上项目(81870614);重庆市卫生适宜推广技术项目(2022jstg042)
DOI：10.16016/j.2097-0927.202404132
中图分类号： R446.62;R543;R587.2收稿：2024-04-28，
修回：2024-08-01，
纸质出版：2024-09-30
- 稿件说明：
移动端阅览
杨若梅, 刘玉双, 江南, 等. 系统免疫炎症指数与2型糖尿病下肢血管病变的相关性研究[J]. 陆军军医大学学报, 2024,46(18):2138-2144.
Ruomei YANG, Yushuang LIU, Nan JIANG, et al. Correlation between systemic immune-inflammation index and lower extremity vascular disease in patients with type 2 diabetes mellitus[J]. Journal of Army Medical University, 2024, 46(18): 2138-2144.
杨若梅, 刘玉双, 江南, 等. 系统免疫炎症指数与2型糖尿病下肢血管病变的相关性研究[J]. 陆军军医大学学报, 2024,46(18):2138-2144. DOI： 10.16016/j.2097-0927.202404132.
Ruomei YANG, Yushuang LIU, Nan JIANG, et al. Correlation between systemic immune-inflammation index and lower extremity vascular disease in patients with type 2 diabetes mellitus[J]. Journal of Army Medical University, 2024, 46(18): 2138-2144. DOI： 10.16016/j.2097-0927.202404132.
摘要
目的
2
探讨系统免疫炎症指数(systemic immune-inflammation index
SII)与2型糖尿病(type 2 diabetes mellitus
T2DM)患者下肢血管病变的关系。
方法
2
采用横断面研究设计，收集2013年1月至2024年1月在我科诊治的390例T2DM患者资料，根据T2DM下肢血管病变诊断标准分为T2DM有下肢血管病变组(
n
=158)和无下肢血管病变对照组(
n
=232)，分析2组之间的一般资料、实验室检查结果等差异。采用Spearman相关分析研究与T2DM下肢血管病变的相关因素。采用Row Mean S
cores和Cochran-Armitage Trend检验研究SII与T2DM下肢血管病变的关系。采用多因素“向前：LR”Logistic回归分析研究T2DM下肢血管病变的危险因素。采用受试者工作特征曲线评估SII对T2DM下肢血管病变的诊断效能。
结果
2
与无下肢血管病变的T2DM患者相比，T2DM下肢血管病变患者的年龄较大，总胆固醇(total cholesterol
TC)、低密度脂蛋白胆固醇(low density lipoprotein cholesterol
LDL-C)和SII水平较高，颈动脉血管病变的比例增加，未服用他汀类药物占比增加。下肢血管病变与SII/100(
r
=0.429
P
<
0.001)、年龄(
r
=0.517
P
<
0.001)、TC(
r
=0.161
P
=0.001)、LDL-C(
r
=0.117
P
=0.021)、颈动脉病变(
r
=0.101
P
=0.047)、未服用他汀类药物(
r
=0.266
P
<
0.001)呈正相关。Logistic回归分析显示，SII、年龄、LDL-C、未服用他汀类药物是T2DM下肢血管病变的危险因素(
P
<
0.01)。SII联合年龄、LDL-C和未服用他汀类药物预测T2DM下肢血管病变的曲线下面积为0.896。
结论
2
SII不仅是T2DM下肢血管病变的危险因素，也是反映T2DM下肢血管病变的简便标志物，提示炎症反应对T2DM的下肢血管病变发生发展具有重要作用。
Abstract
Objective
2
To investigate the relationship between systemic immune-inflammation index (SII) and lower extremity vascular disease in patients with type 2 diabetes mellitus (T2DM).
Methods
2
A cross-sectional study was conducted on 390 T2DM patients admitted in our department from January 2013 to January 2024. According to the diagnostic criteria for lower extremity vascular disease in T2DM patients
they were divided into a lower extremity vascular disease group (
n
=158) and a control group (
n
=232). General data and results of laboratory tests were compared between the 2 groups. Spearman correlation analysis was used to identify the related factors for lower extremity vascular diseases in T2DM patients. The correlation between SII and lower extremity vascular diseases in T2DM patients was analyzed using the Row Mean Scores and Cochran-Armitage Trend analysis. Multivariate logistic regression analysis was applied to identify the risk factors for lower limb va
scular lesions in T2DM patients. Receiver operating characteristic (ROC) curve was plotted to evaluate the diagnostic efficacy of SII for lower extremity vascular disease in the patients.
Results
2
Compared with T2DM patients without lower extremity vascular disease
those with lower extremity vascular disease were older
had higher levels of total cholesterol (TC)
low-density lipoprotein cholesterol (LDL-C)
SII
larger proportion of carotid vascular lesions
and increased proportion of no-taking statins. The lower extremity vascular disease in T2DM patients was positively correlated with SII/100 (
r
=0.429
P
<
0.001)
age (
r
=0.517
P
<
0.001)
TC (
r
=0.161
P
=0.001)
LDL-C (
r
=0.117
P
=0.021)
carotid artery lesions (
r
=0.101
P
=0.047)
no-taking statins (
r
=0.266
P
<
0.001). Logistic regression analysis showed that SII
age
LDL-C
and no-taking statins were the risk factors for lower extremity vascular lesions in T2DM patients (
P
<
0.01). The area under the curve (AUC) value of SII combined with age
LDL-C
and no-taking statins in predicting lower extremity vascular disease in T2DM patients was 0.896.
Conclusion
2
SII is not only a risk factor
but also a simple marker for lower extremity vascular disease in T2DM patients
suggesting that inflammatory response plays an important role in the occurrence and development of lower extremity vascular disease in T2DM.
关键词
Keywords
references
HANG X C, YU X H, FAN S Y. Lower extremity arterial plaque in patients with type 2 diabetes mellitus: a cross-sectional study of 25-(OH)D 3 and other risk factors[J ] . J Diabetes Complicat, 2024, 38(1): 108665. DOI: 10.1016/j.jdiacomp.2023.108665.
CRIQUI M H, MATSUSHITA K, ABOYANS V, et al . Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association[J ] . Circulation, 2021, 144(9): e171-e191. DOI: 10.1161/CIR.0000000000001005.
ZHU Y, XU M D, LI J N, et al . Peripheral white blood cell subtypes and the development/progression of diabetic macular edema in type 2 diabetic patients: a comparative study[J ] . Ann Palliat Med, 2022, 11(9): 2887-2896. DOI: 10.21037/apm-22-962.
LAINAMPETCH J, PANPRATHIP P, PHOSAT C, et al . Association of tumor necrosis factor alpha, interleukin 6, and C-reactive protein with the risk of developing type 2 diabetes: a retrospective cohort study of rural Thais [J ] . J Diabetes Res, 2019, 2019: 9051929. DOI: 10.1155/2019/9051929..
LIU N N, SHENG J L, PAN T R, et al . Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with lower extremity vascular lesions in Chinese patients with type 2 diabetes[J ] . Clin Lab, 2019, 65(3). DOI: 10.7754/Clin.Lab.2018.180804.
LIU Y H, YE T, CHEN L, et al . Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease[J ] . Coron Artery Dis, 2021, 32(8): 715-720. DOI: 10.1097/MCA.0000000000001037.
YE Z, HU T Y, WANG J, et al . Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis[J ] . Front Cardiovasc Med, 2022, 9: 933913. DOI: 10.3389/fcvm.2022.933913.
WANG H, NIE H Y, BU G, et al . Systemic immune -inflammation index (SII) and the risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality in the general population[J ] . Eur J Med Res, 2023, 28(1): 575. DOI: 10.1186/s40001-023-01529-1.
CHEN Q, REN S Q, CUI S P, et al . Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy[J ] . Front Oncol, 2023, 13: 1122811. DOI: 10.3389/fonc.2023.1122811.
HE K, SI L X, PAN X H, et al . Preoperative systemic immune-inflammation index (SII) as a superior predictor of long-term survival outcome in patients with stage Ⅰ-Ⅱ gastric cancer after radical surgery[J ] . Front Oncol, 2022, 12: 829689. DOI: 10.3389/fonc.2022.829689.
HUANG Y H, CHEN Y, ZHU Y, et al . Postoperative systemic immune-inflammation index (SII): a superior prognostic factor of endometrial cancer[J ] . Front Surg, 2021, 8: 704235. DOI: 10.3389/fsurg.2021.704235.
LI J, ZHANG X, ZHANG Y, et al . Increased systemic immune-inflammation index was associated with type 2 diabetic peripheral neuropathy: a cross-sectional study in the Chinese population[J ] . J Inflamm Res, 2023, 16: 6039-6053. DOI: 10.2147/JIR.S433843.
ÖZATA GÜNDOǦDU K, DOǦAN E, ÇELIK E, et al . Serum inflammatory marker levels in serous macular detachment secondary to diabetic macular edema[J ] . Eur J Ophthalmol, 2022, 32(6): 3637-3643. DOI: 10.1177/11206721221083465.
GUO W C, SONG Y C, SUN Y, et al . Systemic immune-inflammation index is associated with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from NHANES 2011-2018[J ] . Front Endocrinol, 2022, 13: 1071465. DOI: 10.3389/fendo.2022.1071465.
OZER BALIN S, OZCAN E C, UǦUR K. A new inflam-matory marker of clinical and diagnostic importance in diabetic foot infection: systemic immune-inflammationindex[J]. Int J Low Extrem Wounds, 2022, 153473462211 30817. DOI: 10.1177/15347346221130817.
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. DOI: 10.3760/cma.j.cn115791-20210221-00095.
Chinese Diabetes Society of Chinese Medical Association.Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabetes Mellitus, 2021, 13(4): 315-409. DOI: 10.3760/cma.j.cn115791-20210221-00095.
中华医学会糖尿病学分会, 中华医学会感染病学分会, 中华医学会组织修复与再生分会. 中国糖尿病足防治指南(2019版)(Ⅱ)[J]. 中华糖尿病杂志, 2019, 11(3): 161-189. DOI: 10.3760/cma.j.issn.1674-5809.2019.03.005.
Chinese Diabetes Society of Chinese Medical Association, Chinese Society of Infectious Diseases of Chinese Medical Association, Chinese Society for Tissue Repair and Regeneration of Chinese Medical Association. Chinese guideline on prevention and management of diabetic foot (2019 edition)(Ⅱ)[J]. Chin J Diabetes Mellitus, 2019, 11(3): 161-189. DOI: 10.3760/cma.j.issn.1674-5809.2019.03.005.
SEVER P S, POULTER N R, DAHLÖF B, et al . Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)[J ] . Am J Cardiol, 2005, 96(5A): 39F-44F. DOI: 10.1016/j.amjcard.2005.06.025.
SAIGUSA R, WINKELS H, LEY K. T cell subsets and functions in atherosclerosis[J]. Nat RevCardiol, 2020, 17(7): 387-401. DOI: 10.1038/s41569-020-0352-5.
GOLDIN A, BECKMAN J A, SCHMIDT A M, et al . Advanced glycation end products: sparking the development of diabetic vascular injury[J ] . Circulation, 2006, 114(6): 597-605. DOI: 10.1161/CIRCULATIONAHA.106.621854.
LIU X B, WANG Y Y, BAUER A T, et al . Neutrophils activated by membrane attack comple xes increase the permeability of melanoma blood vessels[J ] . Proc Natl Acad Sci U S A, 2022, 119(33): e2122716119. DOI: 10.1073/pnas.2122716119.
BAKOGIANNIS C, SACHSE M, STAMATELOPOULOS K, et al . Platelet-derived chemokines in inflammation and atherosclerosis[J ] . Cytokine, 2019, 122: 154157. DOI: 10.1016/j.cyto.2017.09.013.
ZHANG X, DING R, LI H, et al . An association between inflammation and cerebral venous thrombosis: a retrospective study[J ] . J Stroke Cerebrovasc Dis, 2021, 30(11): 106084. DOI: 10.1016/j.jstrokecerebrovasdis.2021.106084.
LIU J J, LI S, ZHANG S, et al . Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab[J ] . J Clin Lab Anal, 2019, 33(8): e22964. DOI: 10.1002/jcla.22964.
CHAKRABORTY S, VERMA A, GARG R, et al . Cardiometabolic risk factors associated with type 2 diabetes mellitus: a mechanistic insight[J ] . Clin Med Insights Endocrinol Diabetes, 2023, 16: 11795514231220780. DOI: 10.1177/11795514231220780.
MAHEMUTI N, JING X Y, ZHANG N J, et al . Association between systemic immunity-inflammation index and hyperlipidemia: a population-based study from the NHANES (2015-2020)[J ] . Nutrients, 2023, 15(5): 1177. DOI: 10.3390/nu15051177.
WANG P B, GUO X F, ZHOU Y, et al . Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population[J ] . Front Endocrinol, 2022, 13: 944991. DOI: 10.3389/fendo.2022.944991.
张晓梅, 许樟荣, 冉兴无, 等. 中国2型糖尿病下肢动脉病变的筛查研究: China-DiaLEAD研究临床意义与结果解读[J]. 中华糖尿病杂志, 2020, 12(11): 870-873. DOI: 10.3760/cma.j.cn115791-20200731-00473.
ZHANG X M, XU Z R, RAN X W, et al . Screening study of lower extremity arterial disease in type 2 diabetes mellitus in China: clinical significance and result interpretation of China-DiaLEAD study[J ] . Chin J Diabetes Mellitus, 2020, 12(11): 870-873. DOI: 10.3760/cma.j.cn115791-20200731-00473.
0
浏览量
316
下载量
1
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
